Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
Biocept (BIOC) - Total assets
Total assets on the balance sheet as of June 2023 : $22.1 M
According to Biocept 's latest financial reports the company's total assets are $22.1 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Biocept - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $30.87 M | -48.9% |
| 2021-12-31 | $60.41 M | 27.32% |
| 2020-12-31 | $47.45 M | 167.59% |
| 2019-12-31 | $17.73 M | 102.65% |
| 2018-12-31 | $8.75 M | 18.59% |
| 2017-12-31 | $7.37 M | -2.63% |
| 2016-12-31 | $7.57 M | -28.42% |
| 2015-12-31 | $10.58 M | 60.69% |
| 2014-12-31 | $6.58 M | 395.46% |
| 2013-12-31 | $1.32 M | -9.52% |
| 2012-12-31 | $1.46 M | -28.64% |
| 2011-12-31 | $2.05 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $1.11 B | 4,944.16% | 🇺🇸 USA |
 Exact Sciences EXAS | $6.47 B | 29,178.06% | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.14 B | 5,087.08% | 🇺🇸 USA |